Policy Notices

• Requirement for Trainee Diversity Report to be Submitted Electronically for Institutional Research Training, Career Development, and Research Education Awards Beginning in Early FY 2021
  (NOT-OD-20-178)
  National Institutes of Health
  

• RESCINDED - Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: August/October 2021 Councils
  (NOT-OD-20-179)
  National Institutes of Health
  

• Required Submission of Financial Conflict of Interest Policy into the eRA Commons Institution Profile (IPF) Module
  (NOT-OD-21-002)
  National Institutes of Health
  

• Reminder: Annual Reports to the Office of Laboratory Animal Welfare due December 1, 2020
  (NOT-OD-21-003)
  National Institutes of Health
  

General Notices

• Collaborative Research in Computational Neuroscience (CRCNS) NSF Innovative Approaches to Science and Engineering Research on Brain Function
  (NOT-MH-20-110)
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  

• Register for the 2020 NIH Virtual Seminar on Program Funding and Grants Administration - Oct. 27-30
  (NOT-OD-21-004)
  National Institutes of Health
  

• Changes to Budget/Project Period for Commercial Fishing Occupational Safety Research Cooperative Agreement (U01)
  (NOT-OH-20-014)
  National Institute for Occupational Safety and Health
  

• Changes to Budget/Project Period for Commercial Fishing Occupational Safety Training Project Grants (T03)
  (NOT-OH-20-015)
  National Institute for Occupational Safety and Health
  

• Notice for All of Us Research Program - National, State, and Local Engagement Partner Funding Opportunity (OT2) and Informational Webinar
  (NOT-PM-20-002)
  National Institutes of Health
  

Notice of Changes to Funding Opportunities

• Notice of Correction to PAR-20-225, " Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)"
  (NOT-DA-20-093)
  National Institute on Drug Abuse
  

• Notice of Correction to Page Limitation Instructions for RFA-DK-20-017: Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Field Epidemiology Sites (U01 Clinical Trial Not Allowed)
  (NOT-DK-20-050)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Change to Due Date for PAR-19-342: Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5)
  (NOT-GM-20-055)
  National Institute of General Medical Sciences
  

• NIMHD Withdraws Participation in NOT-MD-20-019 "Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities"
  (NOT-MD-21-001)
  National Institute on Minority Health and Health Disparities
  

• NIMHD Withdraws Participation in NOT-MD-20-022 "Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations"
  (NOT-MD-21-002)
  National Institute on Minority Health and Health Disparities
  

• Notice of Temporary Extension of Eligibility for the BRAIN Initiative Diversity K99/R00 Career Transition Award During the COVID-19 Pandemic
  (NOT-NS-21-004)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  

Notices of Special Interest

• Notice of Special Interest: Small Grants for Secondary Analyses of Existing Data Sets and Stored Biospecimens
  (NOT-HD-20-022)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Special Interest (NOSI) Research on Rehabilitation Needs Associated with the COVID-19 Pandemic
  (NOT-HD-20-031)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Special Interest (NOSI): Clarification of the Objectives and Program Elements in NHGRI Applications Submitted in Response to the "Ruth L. Kirschstein NRSA Institutional Research Training Grants (Parent T32)"
  (NOT-HG-21-010)
  National Human Genome Research Institute
  

Funding Opportunities

• Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required)
  (PAR-20-305)
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is January 25, 2021. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
  
  

• Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)
  (PAR-20-310)
  National Institute on Minority Health and Health Disparities
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health
  Application Receipt Date(s): November 27, 2020; March 17, 2021; November 17, 2021; March 17, 2022; November 17 2022; February 17, 2023.
  
  

• Multidisciplinary Approaches to HIV-Associated Comorbidities and Prioritizing Intervention Targets (R01 Clinical Trial Not Allowed)
  (PAR-21-027)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
  
  

• Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)
  (PAR-21-044)
  National Institute on Drug Abuse
  Application Receipt Date(s): April 30, 2021, October 29, 2021, April 29, 2022, October 31, 2022, April 28, 2023, October 31, 2023.
  
  

• Understanding the Role of the M. Tuberculosis Granuloma in Tuberculosis (TB) Disease and Treatment Outcomes (R01 Clinical Trial Not Allowed)
  (RFA-AI-20-057)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): February 22, 2021
  
  

• Cohort Studies To Improve Our Understanding of Influenza Immunity, Vaccine Response and Effectiveness in Older Adults (65 years and older) (U01 Clinical Trial Not Allowed)
  (RFA-AI-20-060)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): February 4, 2021
  
  

• Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed)
  (RFA-HD-21-030)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date listed below.